RBX1 and plasma cell myeloma: In the application of DrugFormer to the scRNA‐seq data of multiple myeloma, we unveiled a specific cancer cell state exhibiting stronger drug resistance while presenting elevated expressions of FEN1, RBX1, and COX8A.